Click here to close Hello! We notice that you are using Internet Explorer, which is not supported by Echinobase and may cause the site to display incorrectly. We suggest using a current version of Chrome, FireFox, or Safari.
Echinobase
ECB-ART-46142
Mar Drugs 2018 Feb 19;162:. doi: 10.3390/md16020064.
Show Gene links Show Anatomy links

The Anti-Cancer Effects of Frondoside A.

Adrian TE , Collin P .


???displayArticle.abstract???
Frondoside A is a triterpenoid glycoside from the Atlantic Sea Cucumber, Cucumariafrondosa. Frondoside A has a broad spectrum of anti-cancer effects, including induction of cellular apoptosis, inhibition of cancer cell growth, migration, invasion, formation of metastases, and angiogenesis. In cell lines and animal models studied to date, the anti-cancer effects of the compound are seen in all solid cancers, lymphomas, and leukemias studied to date. These effects appear to be due to potent inhibition of p21-activated kinase 1 (PAK1), which is up-regulated in many cancers. In mouse models, frondoside A has synergistic effects with conventional chemotherapeutic agents, such as gemcitabine, paclitaxel, and cisplatin. Frondoside A administration is well-tolerated. No side effects have been reported and the compound has no significant effects on body weight, blood cells, or on hepatic and renal function tests after long-term administration. Frondoside A may be valuable in the treatment of malignancies, either as a single agent or in combination with other therapeutic modalities.

???displayArticle.pubmedLink??? 29463049
???displayArticle.pmcLink??? PMC5852492
???displayArticle.link??? Mar Drugs


Genes referenced: LOC100887844 LOC100893907 LOC115919910 LOC592256


???attribute.lit??? ???displayArticles.show???
References [+] :
Adrian, Novel marine-derived anti-cancer agents. 2007, Pubmed